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Although the effects of commensal bacteria on intestinal immune
development seem to be profound, it remains speculative whether
the gut microbiota inﬂuences extraintestinal biological functions.
Multiple sclerosis (MS) is a devastating autoimmune disease leading
to progressive deterioration of neurological function. Although the
cause of MS is unknown, microorganisms seem to be important for
the onset and/or progression of disease. However, it is unclear how
microbial colonization, either symbiotic or infectious, affects auto-
immunity. Herein, we investigate a role for the microbiota during
the induction of experimental autoimmune encephalomyelitis (EAE),
an animal model for MS. Mice maintained under germ-free con-
ditions develop signiﬁcantly attenuated EAE compared with con-
ventionally colonized mice. Germ-free animals, induced for EAE,
produce lower levels of the proinﬂammatory cytokines IFN-γ and IL-
17A in both the intestine and spinal cord but display a reciprocal
increase in CD4+CD25+Foxp3+ regulatory T cells (Tregs). Mechanisti-
cally, we show that gut dendritic cells from germ-free animals are
reduced in the ability to stimulate proinﬂammatory T cell responses.
Intestinal colonization with segmented ﬁlamentous bacteria (SFB) is
known to promote IL-17 production in the gut; here, we show that
SFBs also induced IL-17A–producing CD4+ T cells (Th17) in the CNS.
Remarkably, germ-free animals harboring SFBs alone developed
EAE, showing that gut bacteria can affect neurologic inﬂammation.
These ﬁndings reveal that the intestinal microbiota profoundly
impacts the balance between pro- and antiinﬂammatory immune
responses during EAE and suggest that modulation of gut bacteria
may provide therapeutic targets for extraintestinal inﬂammatory
diseases such as MS.
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Immunologic dysregulation is the cause of numerous humandisorders. Multiple sclerosis (MS) is an autoimmune disease that
affects the CNS (1). Common early symptoms include numbness,
pain, burning, and itching of the extremities. Cognitive problems
include memory disturbances, decreased judgment, and inatten-
tion. In extreme cases, MS patients develop partial or complete
paralysis and dementia. The inﬂammatory response in MS is di-
rected to myelin, the protective coating of nerves. Disease involves
uncontrolled autoreactive T cells and additional cells of the im-
mune system that inﬁltrate the CNS and attack the myelin sheath
(2). Although signiﬁcant clinical and scientiﬁc efforts have been
expended for decades, many aspects regarding the nature of MS
are still unknown. However, it is apparent that disease progression
involves genetic as well as environmental factors. Genome-wide
association studies have revealed polymorphisms in several candi-
date genes that encode for cytokines and their receptors as well as
immunoregulatory molecules associated with various autoimmune
disorders (3). However, high rates of discordance in monozygotic
twins, where concordance does not exceed 30% (4), indicate that
environmental factors may play an equal or even more important
role than genetics in the development of MS.
Experimental autoimmune encephalomyelitis (EAE) is an
animal model that reproduces many of the features of MS (5).
EAE is induced by immunization with CNS antigens, including
myelin basic protein (MBP), myelin oligodendrocyte glycopro-
tein (MOG), or proteolipid protein (PLP) or their immunodo-
minant peptides. Myelin-reactive T cells that induce EAE are
only pathogenic in wild-type mice if activated with the self-an-
tigen in the presence of bacterial adjuvants, such asMycobacteria
tuberculosis extracts and/or pertussis toxin. Furthermore, several
reports have suggested that MS in humans is associated with
microbial contact; paradoxically, some microorganisms seem to
potentiate disease, whereas others seem to prevent MS (6).
Therefore, altered microbial stimulation of the immune system
may be a likely underlying environmental component of disease.
Although infections may affect immune responses, encounters
with pathogenic microbes are relatively rare and opportunistic.
Conversely, environmentally exposed surfaces of mammals are
colonized for life with 100 trillion indigenous bacteria, creating
a diverse ecosystem whose contributions to human health seem
to be profound (7). The gastrointestinal tract harbors the
greatest numbers and complexity of microorganisms, known as
the microbiota, which have evolved with their hosts for millions
of years and regulate human nutrition, metabolism, and immune-
system function. Furthermore, the intestinal microbiota contains
both pro- and antiinﬂammatory products that modulate immune
responses (8). Therefore, the community composition of the
microbiota may have profound effects on the immune status of
the host and may impact the development and/or progression of
inﬂammatory diseases such as MS.
After lineage commitment in the thymus, naïve CD4+ T cells
enter the periphery where they sense environmental signals that
further instruct their maturation and function. During responses
to infectious disease, microbial and host signals at the site of in-
fection provide cues to naïve T cells to induce their differentiation
into various pro- and antiinﬂammatory subsets. For instance, in-
fection by intracellular pathogens drives the development of
T-helper 1 (Th1) cells, whereas responses to extracellular patho-
gens are predominantly of the Th2 and Th17 subset (9). These
proinﬂammatory T-helper cells coordinate many aspects of the
innate and adaptive immune response to effectively clear microbial
invaders. Although T cells presumably evolved to control microbial
infections, unrestrained and indiscriminate T cell responses lead to
host destructive pathologies such as inﬂammatory bowel disease
(IBD), type 1 diabetes (T1D), rheumatoid arthritis (RA), and MS.
This paper results from the Arthur M. Sackler Colloquium of the National Academy of
Sciences, "Microbes and Health" held November 2–3, 2009, at the Arnold and Mabel
Beckman Center of the National Academies of Sciences and Engineering in Irvine, CA.
The complete program and audio ﬁles of most presentations are available on the NAS
Web site at http://www.nasonline.org/SACKLER_Microbes_and_Health.
Author contributions: Y.K.L. and S.K.M. designed research; Y.K.L. and J.S.M. performed
research; Y.U. contributed new reagents/analytic tools; Y.K.L., J.S.M., and S.K.M. analyzed
data; and Y.K.L., J.S.M., and S.K.M. wrote the paper.
The authors declare no conﬂict of interest.
This article is a PNAS Direct Submission.
1Y.K.L. and J.S.M. contributed equally to this work.
2To whom correspondence should be addressed. E-mail: sarkis@caltech.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1000082107/-/DCSupplemental.
www.pnas.org/cgi/doi/10.1073/pnas.1000082107 PNAS | March 15, 2011 | vol. 108 | suppl. 1 | 4615–4622
A primary and dominant mechanism to prevent deleterious self-
reactions is mediated by regulatory T cells (Tregs) (10). Various
subsets of CD4+ Treg cells control organ-speciﬁc autoimmunity
and are also induced at the site of infection to dampen immune
responses after pathogen clearance. Microbial signals and the
immune environment that they create during infection modulate
the peripheral function of T cells. A series of recent studies now
reveals that noninfectious symbiotic microbes ﬁne tune CD4+
T cell responses (11). Therefore, how the microbiota inﬂuences the
T-helper/Treg axis seems to be a critical component of various
immune-mediated diseases.
Recent studies have begun to reveal the extraordinary di-
versity and complexity of the ecosystem that we provide to
microorganisms. Advances in genomic technologies have shown
that humans harbor dozens of bacterial species in our stomachs,
hundreds on our skin and oral cavity, and thousands within our
lower gastrointestinal (GI) tract (12–14). The magnitude of these
interactions and the evolutionary forces that drive them must
exert profound inﬂuences on the biology of both microbe and
man. Although the contribution of the microbiota to GI function
is well-documented, recent speculations propose that gut bac-
teria may control extraintestinal biological functions. Herein, we
investigate the concept that commensal microbes can inﬂuence
immune responses distant from mucosal surfaces by examining
the role of the microbiota on the onset and severity of EAE. We
show that germ-free animals, devoid of all microbial colonization,
develop signiﬁcantly reduced neuro-immune disease symptoms
and pathology and express lower levels of inﬂammatory cytokines
associated with EAE compared with mice colonized with a com-
plete microbiota. During EAE induction, germ-free animals dis-
play higher levels of Foxp3+ Treg cells in various lymphoid tissues.
Furthermore, germ-free mice induced to develop EAE display
reduced Th1/Th17 proinﬂammatory responses in the CNS. The
reduction in proinﬂammatory T cell responses seems to involve
a defect in the innate immune system, because dendritic cells
(DCs) from germ-free animals do not prime MOG-speciﬁc T cell
activation as efﬁciently as DCs from colonized animals. To de-
termine if speciﬁc microbial species can drive inﬂammation in the
CNS, we colonized germ-free animals with segmented ﬁlamentous
bacteria (SFBs), which are known to induce Th17 cells in the gut.
Remarkably, SFB-monoassociated animals showed increased
Th17 cell responses in both the colon and small intestine as well as
within the spinal cords of animals. Most importantly, animals
colonized intestinally with SFBs developed EAE on immunization
with self-antigens. Collectively, these studies suggest that the
microbiota contains organisms that direct both pro- and antiin-
ﬂammatory immune responses in the CNS. Understanding the
role of the microbiota in directing host immune responses may
be critical in the design of rational therapies for MS.
Results
Germ-Free Mice Are Highly Resistant to the Development of EAE. To
evaluate the role of the microbiota on EAE induction, C57BL/6
mice maintained under sterile (germ-free; GF) or speciﬁc patho-
gen-free (SPF) conditions were immunized with MOG peptide in
complete Freund’s adjuvant (CFA). This procedure expands and
activates an antigen-speciﬁc T cell response that leads to inﬂam-
mation targeted to the myelin sheath. Animals were monitored for
signs of EAE, and disease onset and progression between groups
were assessed by a standard scoring system (5). After disease in-
duction, SPF animals displayed a typical course of disease, where
animals exhibited symptoms beginning at day 10–12 and regressing
by day 35 postimmunization (Fig. 1A). Remarkably, GF mice
showed signiﬁcantly attenuated signs of disease as shown by their
EAE scores compared with SPF animals. With our immunization
protocol, most SPF animals developed EAE, whereas only some
GF animals showed any signs of disease (Fig. 1B), and those that
did develop EAE had reduced clinical scores, reﬂected by milder
paralysis and shorter duration of EAE symptoms. We next as-
sessed disease onset by examining tissues for both an inﬂammatory
response and pathology. During EAE, immune cells migrate into
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Fig. 1. GF mice develop less severe EAE than SPF mice. (A) Clinical EAE
scores of SPF (dark symbols) and GF (light symbols) mice immunized with
MOG peptide in CFA plus pertussis toxin. Data are representative of three
independent experiments. Symbols represent the mean ± SD at each time
point. (B) Proportions of SPF and GF mice that develop various degrees of
EAE. Results are combined from four independent experiments, with a total
number of animals per group of 20 for SPF and 22 for GF mice. (C) H&E
(Upper) and myelin basic protein (Lower) staining of the spinal cord of SPF
and GF mice at the onset of EAE on day 12. Each panel is representative of
tissue analyzed from at least four mice. (D) EAE score of conventional Rag−/−
recipient mice (n = 4) that were reconstituted with in vitro primed CD4+ cells
from SPF (black symbols) or GF (gray symbols) mice immunized with MOG/
CFA and pertussis toxin. Data are representative of three independent
experiments. Symbols represent the mean ± SD at each time point.
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the CNS and mediate tissue destruction. Histological staining of
the spinal cords of animals revealed that SPF mice had increased
inﬁltration of leukocytes into the CNS and greater erosion of the
myelin sheath compared with GF animals (Fig. 1C). Therefore,
the basis for why GF animals do not develop disease seems to
involve the absence of the inﬂammatory cascade in the CNS that is
observed in SPF mice. These results indicate that the microbiota
potentiates the induction of EAE.
CD4+ T Cells from GF Animals Can Be Activated to Induce EAE. Be-
cause GF animals have deﬁcits in the development of certain
inﬂammatory T cell subsets (15, 16), the reduction in EAE de-
velopment may reﬂect an inability to activate a proinﬂammatory
self-reactive T cell response. To investigate whether self-reactive
T cells from GF can induce EAE, lymphoid cells from MOG/
CFA-immunized SPF or GF mice were harvested 8–10 d post-
immunization and restimulated in vitro with MOG peptide to
induce an antigen-speciﬁc inﬂammatory response. After in vitro
stimulation with antigen, CD4+ T cells were subsequently trans-
ferred into recombination activating gene (RAG)-deﬁcient SPF
mice (lacking T and B cells), and the development of EAE was
monitored. Interestingly, CD4+ T cells from GF animals retained
the capacity to promote disease when stimulated under in-
ﬂammatory conditions, albeit to a slightly lower degree than cells
from SPF mice (Fig. 1D). Recipient animals adoptively trans-
ferred with CD4+ T cells from GF mice developed EAE with
kinetics similar to those of animals repopulated with T cells from
SPF animals. However, the overall magnitude of disease in cells
from GF donors was lower than that of SPF animals (although
clearly increased from that of completely GF mice, as in Fig. 1A).
Although the reason for this intermediate phenotype remains
unclear, it may be because of incomplete microbial stimulation of
cells by the SPF microbiota after transfer or an increased pro-
portion of transferred Tregs from germ-free donor animals. In
either case, our ﬁndings show that T cells fromGF animals are not
inherently unresponsive, suggesting that their inﬂammatory status
is actively regulated by the microbiota. These results indicate that
cells from GF mice can be reprimed on in vitro stimulation to in-
duce EAE and that microbial interactions with the host immune
system control inﬂammation in the CNS. Therefore, the micro-
biota dynamically and reversibly impacts the programming of
pathogenic immune responses during autoimmunity.
Animals Resistant to EAE Display Reduced Proinﬂammatory Responses.
EAE is driven largely by a proinﬂammatory T cell response that
coordinates the inﬁltration of immune cells into the CNS. Var-
ious subsets of T-helper cells have been shown to potentiate
disease, and both Th1 and Th17 reactions seem to be highly
associated with the development of EAE. As mentioned earlier,
infection by pathogens induce Th1 and Th17 immunity. These
proinﬂammatory T-helper cells coordinate many aspects of the
innate and adaptive immune response to effectively clear mi-
crobial invaders. Commensal bacteria also share the ability to
activate these subsets of cells; however, it seems the microbiota
activates/expands T-helper cells in a controlled manner without
causing pathologic inﬂammation (17). If the microbiota aug-
ments our immune system by sustaining basal inﬂammatory T
helper cells to better protect their host against infectious disease,
would they also prime our self-immune system to autoimmunity?
We, therefore, investigated if GF animals were reduced in their
proinﬂammatory T cell responses on EAE induction. Animals
were immunized with MOG/CFA, and cells were recovered from
draining lymph nodes of SPF and GF mice before the onset of
disease (day 8) and restimulated in vitrowithMOGpeptide.After 3
d of in vitro culture stimulation, the proinﬂammatory proﬁle of
CD4+ T cells was assessed. Analysis of the canonical Th1 cytokine
(IFN-γ) and the Th17 cytokine IL-17A by intracellular cytokine
staining revealed increased proinﬂammatory T cells in SPF animals
compared with GFmice (Fig. 2A). Accordingly, CD4+IFNγ+ T cell
proportions are signiﬁcantly decreased in GF mice on day 8 after
immunization, before the initial signs of paralysis (Fig. 2B). ELISA
analysis of cultured CD4+ T cells from draining lymph nodes show
that germ-free mice express lower levels of both IFNγ and IL-17A
compared with animals with a complete microbiota (Fig. 2C).
Similar results were found in the spleen during the onset of EAE
(Fig. S1). Therefore, CD4+ T cells from GF animals display a re-
duced systemic proinﬂammatory proﬁle compared with cells from
SPF animals. Cells cultured in the absence of MOG peptide under
the same in vitro conditions resulted in no cytokine production,
showing that the observed proinﬂammatory responses were antigen-
speciﬁc. Lineage differentiation of Th17 cells is mediated by the
orphan nuclear receptor retinoic acid–related orphan receptor
(RORγt), a transcription factor that is required for IL-17A pro-
duction. Furthermore, RORγt-deﬁcient animals do not develop
EAE, showing the importance of Th17 cells for the disease process
(18). We, therefore, analyzed the expression of RORγt in the CNS
of immunized SPF andGF animals. Consistent with the reduction in
IL-17A levels, the transcript for RORγt is greatly decreased in
CD4+ T cells of the CNS of GF animals compared with SPF (Fig.
2D). Recent reports have shown that Th17 cells and RORγt ex-
pression are reduced in theGI tract of GF animals (19, 20); our data
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Fig. 2. Inﬂammation is attenuated in GF mice on EAE induction. (A) Lym-
phocytes were harvested from draining LN of treated SPF and GF mice at 8 d
after immunization with MOG/CFA. Intracellular staining of CD4+ T cell for
IFNγ and IL-17A after 3 d in vitro culture with MOG peptide, restimulated
with phorbol 12-myristate 13-acetate (PMA)/ionomycin for the last 5 h.
Numbers in each quadrant indicate percentage of cytokine-positive CD4+ T
cells. (B) Mean ± SD of the CD4+IFNγ+ T cell subsets from A. Data are rep-
resentative of three independent experiments with at least four mice per
group. (C) Real-time PCR of the transcription factor RORγt in cells isolated by
Percoll gradient from spinal cords of SPF and GF mice at the onset of disease
(day 8). Each symbol represents a single mouse. (D) IFNγ and IL-17A cyto-
kine ELISA from cells harvested from draining LN of SPF and GF mice 8 d
after immunization with MOG/CFA and cultured for 3 d in vitro with MOG
peptide. Data are representative of three independent experiments, with
mean ± SD of samples run in triplicate.
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further these ﬁndings by revealing that both systemic and neuronal
proinﬂammatory Th17 responses are reduced during EAE in the
absence of the microbiota. Collectively, the diminished expression
of Th1 and Th17 responses in GF mice provides a cellular expla-
nation for the observation that microbial colonization of animals
promotes EAE.
Increased Tregs During EAE Induction in GF Mice. A healthy immune
system is designed to balance inﬂammatory responses to invading
microbes with suppressive mechanisms that limit collateral dam-
age to host tissues. Uncontrolled or excessive immune reactions to
pathogens may lead to autoimmunity and other inﬂammatory
diseases. Tregs provide a primary mechanism to suppress aberrant
immune responses and promote protection from inﬂammatory
disease (21). Many Tregs are marked by expression of CD4,
CD25, and the transcription factor Foxp3 (Forkhead Box tran-
scription factor for Treg differentiation). Very intriguingly, mi-
crobial inﬂuences on regulatory T cell function have emerged as
a possible means by which beneﬁcial bacteria may modulate host
immune responses (8). Because Foxp3+ Treg cells are able to
suppress proinﬂammatory T-helper cells that drive autoimmunity
such as EAE, we next investigated the levels of antiinﬂammatory
Tregs during immune responses to MOG in GF and SPF mice.
Cells from the draining lymph nodes and spleen were stimulated
in vitro with MOG peptide 8 or 15 d after immunization, reﬂecting
time points before and during the peak of EAE, respectively.
Astonishingly, analysis by ﬂow cytometry shows that proportions
of CD4+CD25+Foxp3+ Treg cells were increased in GF com-
pared with SPF mice (Fig. 3). At both day 8 (Fig. 3 A and B) and
day 15 (Fig. 3 C and D) after the induction of EAE, animals
without microbial colonization contained signiﬁcantly higher
proportions of Treg cells. This phenotype seems once again to be
antigen-speciﬁc, because no differences in Foxp3+ Treg pro-
portions were observed between groups when cells were cultured
in the absence of MOG peptide (Fig. S2). These results show that
although proinﬂammatory T cell responses to self-antigens are
diminished, GF animals concomitantly display increased Treg cells
in lymphoid organs during resistance to EAE.
Innate Immune Cells from GF Animals Are Defective in Activation of
MOG-Speciﬁc T cells. Our results reveal that the microbiota inﬂu-
ences gut–brain immune responses during EAE. We sought to
determine the cellular nature for the inability of GF animals to
mount autoreactive T cell responses. DCs are capable of priming
various T-helper cell reactions in the gut (22). We, therefore,
puriﬁed CD11c+ DCs from the mesenteric lymph nodes (MLNs)
of GF and SPF animals and cocultured these cells with MOG-
speciﬁc T cells to measure IL-17A and IFNγ production in re-
sponse to MOG peptide. Cytokine analysis revealed that after 3
and 5 d of culture, DCs fromGFmice were defective in promoting
IL-17A (Fig. 4A) or IFNγ (Fig. 4B) expression compared with
DCs harvested from SPF animals. As expected, no cytokine pro-
duction was detected from cocultures without MOG peptide
stimulation, conﬁrming speciﬁc T cell activation. Consequently,
these results show that DCs from germ-free animals have a re-
duced capacity to induce both Th1 and Th17 cell response to
self-antigens, consistent with reduced EAE development in
animals without a microbiota.
Intestinal Colonization with SFB Promotes EAE. The absence of EAE
in GF animals suggests that the microbiota stimulates proin-
ﬂammatory immune responses that lead to inﬂammation and
pathology in the CNS. Over the past few years, it has become
evident that Th17 cells play a pivotal role in EAE development,
once thought to be driven by Th1 cells only. Although the re-
lationship between Th1 and Th17 cells during EAE is an active
area of research, it seems reasonable to propose that members of
the microbiota that promote Th17 cells could initiate the in-
ﬂammatory cascade that ultimately leads to inﬂammation in the
CNS. This notion has been supported by a series of reports that
shows that GF animals are highly reduced in intestinal Th17 cells
(19, 20). Furthermore, recent studies have now identiﬁed that
speciﬁc members of the microbiota, SFBs, are uniquely able to
induce Th17 cell differentiation in the small intestine (17, 23).
We wondered if SFBs were also able to promote the Th17 cell
lineage outside the gut and perhaps, restore the defect in EAE
development found in germ-free mice. Groups of GF animals
were either monocolonized with SFBs (GF-SFB) or left GF and
were compared with conventionally colonized animals for EAE
induction after immunization with MOG peptide. Remarkably,
animals harboring intestinal SFBs alone were highly susceptible
to EAE symptoms compared with GF mice (Fig. 5A). GF mice
were delayed in the onset of disease compared with GF-SFB and
conventionally colonized animals, and the severity of disease was
signiﬁcantly lower in GF mice relative to animals harboring
SFBs. Although colonization with SFBs did not induce EAE to
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Fig. 3. Increase in CD25+Foxp3+ Treg cells after induction of EAE in GF mice.
Intracellular staining of CD4+CD25+Foxp3+ T cells cultured for 3 d with MOG
peptide, restimulated with PMA/ionomycin for the last 5 h. Lymphocytes
were harvested from draining lymph nodes (LN) and spleens of SPF and GF
mice at 8 d p.i. (A and B) or 15 d p.i. (C and D) after i.v. immunization with
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positive cells. In B and D, results are shown for mean ± SD of the CD4+
subsets of the cells from draining LN and spleen on day 8 and day 15 post-
immunization. Data are representative of three independent experiments
with at least four mice per group.
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the maximal level of SPF animals with a complex microbiota,
GF-SFB animals showed pronounced disease compared with GF
mice. These ﬁndings show that speciﬁc intestinal microbial species
known to induce Th17 cells are sufﬁcient to promote disease in
the CNS. It is important to note that SFBs are not overt pathogens
that cause intestinal inﬂammation and/or pathology (24). There-
fore, our studies suggest that the immunomodulatory capacity
of the microbiota extends to extraintestinal sites and highlights
the importance of gut bacteria on immune responses throughout
the body.
Microbiota Regulates Pro- and Antiinﬂammatory Responses in the
Gut and CNS. To determine if colonization with SFBs results in
restoration of T-helper cells that are missing in GF animals, we
examined Th1 and Th17 cell phenotypes in the intestines and
spinal cords of mice induced for EAE. Consistent with our
ﬁndings above that Th1 and Th17 cells are reduced in the spleens
of GF animals, we observed a signiﬁcant decrease in IL-17A– and/
or IFNγ-producing CD4+ T cells in the small-intestinal lamina
propria (SI LPL) in the absence of a microbiota (compare GF and
SPF) (Fig. 5B). Remarkably, CD4+ T cells harvested from the
spinal cords of animals at the peak of disease also showed a de-
crease in IL-17A– and IFNγ-producing single-positive and double-
positive cells. Thus, the microbiota inﬂuences immune responses
in the CNS. Furthermore, monoassociation with SFBs (GF-SFB)
resulted in a considerable increase in proinﬂammatory IL-17A
and IFNγ production in the spinal cords (and intestines) of mice
that succumbed to EAE. In agreement with previous studies that
show that SFBs induce intestinal T-helper cell phenotypes during
steady colonization (17, 23), these data show that IL-17A is also
elevated in the gut during EAE. Furthermore, our ﬁndings reveal
that intestinal colonization with SFBs promotes Th1, Th17, and
double-positive T cells in the spinal cords of mice, providing evi-
dence that gut-bacteria prime immune responses that extend to
the CNS. We conclude that GF animals display highly reduced
EAE symptoms because of a lack of immune stimulation by gut-
bacteria.
We wanted to explore whether the balance between T-helper
and Treg cells was also affected by SFBs. We have shown above
that systemic proportions of Foxp3+ Tregs are increased in GF
animals, and others have shown a similar phenotype in gut tissues
(19). Fig. 5C shows that, consistent with previous reports, Foxp3+
Tregs are increased in the SI of GF mice compared with con-
ventional colonization, and monoassociation with SFBs reduces
the proportion of Tregs in the gut. However, when CD4+ T cells
of the CNS were examined during EAE, GF animals displayed
a signiﬁcant decrease in Foxp3+ Tregs (as well as Th17 cells) (Fig.
5C, spinal cord). Colonization of GF animals with SFBs resulted
in a Th17/Treg proﬁle that was indistinguishable from conven-
tionally colonized animals. It is still unclear whether colonized
animals develop EAE because of increased T-helper cells (or their
activity) or a deﬁciency in Treg function. However, during the
peak of disease, GF animals have reduced pro- and antiinﬂam-
matory T cells in the CNS compared with colonized animals, re-
vealing the profound effects of the microbiota immune responses
in the CNS.
Numerous studies have shown that Foxp3+ Treg cells prevent
autoimmunity (25). It seems that microbial colonization may
provide proinﬂammatory signals that affect the reciprocal de-
velopment of T-helper and Treg cells. Moreover, because sys-
temic and neuronal compartments of animals are devoid of
microbes during normal commensal colonization, our ﬁndings
support a model whereby microorganisms found at mucosal or
environmentally exposed surfaces of the body affect immune
responses that modulate inﬂammatory disease at extraintestinal
anatomical locations. These studies reveal that the microbiota
controls the T-helper/Treg axis outside the gut and suggest that
immune stimulation by the microbiota may be a critical target for
treatment of inﬂammatory diseases such as MS.
Perspective. Reﬂecting a growing medical crisis in Western soci-
eties, recent epidemiologic and clinical reports have revealed
dramatic increases in the incidences of several immune dis-
orders: IBD, asthma and allergies, T1D, RA, and MS (26). The
hygiene hypothesis proposed over two decades ago speculated
that these increases are the result of lifestyle changes and med-
ical advances that reduce exposure to microbial pathogens. Mi-
crobial infections are, in fact, rare and opportunistic. In contrast,
mammals are colonized for life with extraordinary multitudes of
indigenous bacteria, and the contributions of this enormous and
diverse ecosystem to human health remain poorly understood.
Recent studies have launched a revolution in biology aimed at
understanding how (and more importantly, why) mammals har-
bor symbiotic bacteria. We have recently shown that symbiotic
intestinal bacterial molecules direct the development of the
mammalian immune system and confer protection from intestinal
disease (15, 27); thus, fundamental aspects of mammalian health
are absolutely dependent on microbial symbiosis. For example,
microbial diversity within the gut correlates to physiological states
such as obesity and metabolic disease (28, 29). Furthermore, alter-
ations in the community composition of the microbiota, known as
dysbiosis, may be a critical factor in numerous immune-mediated
diseases in humans (e.g., IBD, asthma, and allergies) (8).
It has been suggested for over a decade that microorganisms
contribute to the pathogenesis of MS (30–35). However, ﬁndings
have not been sufﬁcient to establish an etiological or causal re-
lationship between microbes and neurological inﬂammation. The
role of gut bacteria in shaping GI immune responses is well-
accepted, and studies have highlighted a key role for the com-
mensal microbiota in the development of intestinal Th17 cells
(11, 19, 20, 36). GF mice display very low numbers of Th17 cells
within the LP of the intestine compared with SPF animals (19,
20). Moreover, speciﬁc species of bacteria and commensal bac-
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terial molecules have been proposed to modulate Th17 differ-
entiation (17, 19, 23, 37). Thus, the microbiota plays an active
role in the development and function of inﬂammatory T-helper
cell pathways in the gut. However, the direct affects of microbial
colonization on extraintestinal inﬂammatory pathways remain
largely unexplored. Recent reports show that the microbiota
affects the onset of T1D (38) and RA (39) through mechanisms
involving innate immune signaling by bacteria. These studies also
reveal that GF animals display dramatically altered disease onset
(for both T1D and RA) compared with SPF animals. We report
herein that GF animals develop signiﬁcantly reduced EAE,
extending the cadre of autoimmune diseases that are modulated
by the microbiota. Several studies have, however, reported the
use of antibiotics in protecting animals from EAE (40–42). It is
also noteworthy to mention that, in clinical trials studies, the
antibiotic minocycline has shown initial promise as a therapeutic
for human MS (43, 44). The target of the antibiotic (i.e., path-
ogen and/or commensal bacteria) is unknown. Ochoa-Reparaz
et al. (42) have recently shown that oral (but not systemic) an-
tibiotic treatment reduces EAE, speciﬁcally implicating gut
bacteria in the disease process. The proposed mechanism
involves the modulation of intestinal DC subsets that inﬂuence
the function of CD4+CD25+ Treg cells. These studies show the
dynamic nature of the interaction between gut bacteria and the
immune system, because depletion of the microbiota can re-
program systemic immune responses. Although infections have
been speculated for many years to play a role in human diseases
(as posited by the hygiene hypothesis), increasing evidence now
suggests that nonpathogenic microbes may profoundly affect
several autoimmune diseases such as T1D, RA, and EAE.
We reveal that microbial signals from the gut promote in-
ﬂammation in extraintestinal tissues.Remarkably,GFmice develop
signiﬁcantly less paralysis and histological signs of EAE, and con-
cordantly, they display increased Foxp3+ Treg proportions after
induction of disease compared with SPF mice. Presumably, these
Foxp3+ Tregs suppress the increased Th1 and Th17 responses
found in animals on colonization with commensal bacteria. The
basis for why GF animals are resistant to EAE does not seem to be
a defect in T-helper cell function, because CD4+ T cells from GF
animals can promote EAE after in vitro activation with self-antigen
and subsequent transfer into naïve RAG−/− animals. Previously, it
has been shown that autoreactive T cells (speciﬁc for PLP) exist in
GF SJL mice; however, EAE development was never assessed in
this study (45). This is consistent with our ﬁndings suggesting that
the microbiota modulates the Th1/Th17 vs. Treg axis and may not
inﬂuence the presence of autoreactive cells but rather modulates
their immunestatus.Clearly,morework isneeded todeterminehow
autoreactive T cells escape negative selection in the thymus. How-
ever, once in the periphery, it seems that the microbiota plays
a fundamental role in the activation state of T cells—even outside
of the gut.
Because the balance between pro- and antiinﬂammatory re-
sponses is important during many diseases, understanding how
the microbiota shapes immune responses (either in the intestine,
the CNS, or elsewhere) is critical for human health. It has been
well-documented that GF animals do not develop intestinal
disease in animal models of colitis (8). This suggests that mi-
crobial stimulation is required for the immune responses during
IBD, and speciﬁc (potentially pathogenic) members of the mi-
crobiota seem to activate a proinﬂammatory response that leads
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to host pathology. However, it is also known that beneﬁcial
bacteria have evolved mechanisms to ameliorate intestinal in-
ﬂammation and experimental colitis, and several probiotic
therapies for IBD are in development (46). Perhaps, the same
microbial inﬂuences reported for IBD may play a role during MS
(i.e., speciﬁc microbes stimulate T-helper responses, whereas
others prevent them). We propose the hypothesis that dysbiosis
of the intestinal microbiota is an important factor in the de-
velopment and/or severity of MS. Future studies must integrate
the concept that immunologic responses outside the gut are
inﬂuenced by microbial colonization, and accordingly, the design
of therapies for MS may involve probiotic microorganisms that
can modulate inﬂammation of the brain and CNS.
Materials and Methods
Animals. Female C57BL6/J, Rag−/−, and MOG-Tg mice (Jackson Laboratory)
were housed in a conventional or GF facility at Caltech. GF mice were
maintained in sterile isolators and fed autoclaved food and water (Class
Biologically Clean). Mice were screened weekly for contamination by bac-
terial plating and PCR as in ref. 15. GF mice were colonized with SFB by
introduction of fecal pellets from SFB monocolonized mice (47). All proce-
dures were performed according to guidelines of the Institutional Animal
Care Committee at the California Institute of Technology.
Cell Transfer. Cells from spleen and lymph nodes (LN) of immunized mice were
harvested at day 8 postimmunization (p.i.), and 5 × 106 cells were cultured
with MOG35–55 peptide (MEVGWYRSPFSRVVHLYRNGK) and IL-12 for 48–72 h.
The cultured cells were then separated into CD4+ population using MicroBeads
(Miltenyi Biotech) and analyzed for purity by ﬂow cytometry (FC) before trans-
fer (>98% CD4+). Recipient mice were injected with 5 × 106 cells/mouse i.v. and
monitored daily for clinical signs of EAE.
EAE Induction. Groups of SPF or GF mice at 8–10 wk of age were immunized
s.c. with 150 μg MOG35–55 peptide per mouse (Synthetic Biomolecules) and
200 μg of Mycobacterium tuberculosis H37Ra (Difco) divided among three
sites on their backs. On the same day and 2 d later, they will be injected i.p.
with 150 ng/mouse of pertussis toxin (List Biological) in 0.3 mL PBS. Disease
scores were measured as follows: 1, tail paralysis; 2, hindlimb weakness; 3,
hindlimb paralysis; 4, hind and forelimb paralysis; 5, moribund/dead.
Cell Culture.Draining LN and spleen cells from groups of immunized SPF or GF
mice were collected after immunization, resuspended in complete RPMI
medium, and then incubated with media alone or the MOG35–55 peptide.
Intracellular Cytokine Staining. Cells obtained from in vitro cultures were
incubated for 4–5 h with phorbol 12-myristate 13-acetate (50 ng/mL; Sig-
ma) and ionomycin (500 ng/mL; Sigma) plus brefeldin A (2 μg/mL; Sigma)
for the ﬁnal 2 h. Cell surfaces were stained with the appropriate ﬂuores-
cence-labeled antibodies: anti-CD4 and anti-CD25. After surface staining,
cells were washed and resuspended in Permeabilization-Fixation solution
(BD Cytoﬁx/Cytoperm kit; BD Pharmingen), and intracellular cytokine staining
was performed with appropriate ﬂuorescence-labeled antibodies: anti–IL-17A
and anti–IFN-γ (eBioscience) according to manufacturer’s protocol.
Cytokine ELISA. Supernatant obtained from in vitro cultures was analyzed for
IL-17A and IFN-γ following the guidelines of the manufacturer’s protocol
(eBioscience).
Quantitative Analysis of mRNA. RNA was extracted using the RNEasy Qiagen
kit following the manufacturer’s protocol and was reverse-transcribed with
oligo(dT) primer (BioRad) according to the manufacturer’s protocol. The
cDNA served as template for ampliﬁcation of target genes as well as the
housekeeping gene L32 by real-time PCR with universal PCR Master Mix
(BioRad). Expression of target genes was calculated by comparison of rela-
tive levels after normalization to L32 expression.
CD4 T Cell Isolation and MLN DC Isolation. Spleens and LN were collected from
SPF or GF mice, and single-cell suspensions were prepared by mechanical
disruption. CD4+ T cells were isolated using negative selection MicroBeads
according to the manufacturer’s protocol (Miltenyi Biotec). For ex vivo DC
isolation, MLNs were digested with collagenase D (100 U/mL) and DNase I (20
μg/mL) for 30 min at 37 °C and then incubated for 5 min in PBS plus EDTA.
CD11C+ DCs from MLNs were enriched using CD11c MicroBeads according to
the manufacturer’s protocol (Miltenyi Biotec); 5 × 105 CD4+ T cells were
cultured with 105 MLN DCs in the absence or presence of 20 μg/mL MOG35–55
peptide and 100 U/mL IL-2.
SI LPL Isolation. Intestines were dissected, Payer’s patches were removed, and
the epithelial layer was also removed by sequential incubation with HBSS
containing DTT (154 μg/mL) followed by 2 μM EDTA. The remaining gut tissue
was digested with 100 U/mL collagenase D and 20 μg/mL DNase I at 37 °C for
30min with gentle agitation. Undigested tissuewas removed by straining, cells
were washed in HBSS, and total lamina propria cells were puriﬁed on 40/80%
Percoll gradient.
Preparation of Spinal Cord Lymphocytes. Spinal cords were cut into pieces and
digested for 30 min at 37 °C with collagenase D and DNase I followed by 40/
80% Percoll gradient.
Statistical Analysis. P values were calculated by the two-tailed Student t test.
Error bars in EAE score data represent the SD at each time point and were
calculated using Prism software (GraphPad).
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